Bacterial Toxins
A section of Toxins (ISSN 2072-6651).
Section Information
The “Bacterial Toxins” section of Toxins invites the submission of high quality manuscripts that report new investigations into all aspects of research on bacterial toxins, including but not limited to: mechanisms of toxin action; toxin transport or processing by host cells; host responses to bacterial toxins; novel properties of bacterial toxins; structure-function studies; mechanisms to detect and neutralize minute quantities of bacterial toxins; toxin evolution and classification; and clinical effects and case reports including applications of bacterial toxins as novel therapeutic compounds, and vaccine development and vaccine testing. The editors will also consider reviews that summarize current thinking or present controversial viewpoints for further discussion. Short communications that report important self-contained observations are also welcome.
Keywords
adaptive immune response; animal modelling; antitoxins; apoptosis; biochemistry; bioinformatics; clinical laboratory; chemokines; clinical trials; cytokines: cytotoxicity; detection methods; diagnostic methods; environmental contaminants; ER stress; evolution; expression; gene expression profiling; inflammasome; intracellular transport; innate immune response; in vitro diagnostics; mechanism of action; molecular modelling; necrosis; next-generation sequencing; NMR; pattern recognition receptors; PCR; pathology; pathophysiology; peptides; pharmacology; pharmacokinetics; phylogeny; physiology; pore formation; protein; proteome; proteomics; purification; qPCR; RT-qPCR; pyroptosis; receptor analogues; receptor interaction; retrograde transport; ribotoxic stress response; taxonomy; therapeutic intervention; therapeutic molecules; toxin; toxinology; transcriptome; transcriptomics; unfolded protein response (UPR); vaccines; X-ray crystallography
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- The Role of Botulinum Toxin Injections in Long-Term Management of Spasticity in Chronic Post-stroke Patients (Deadline: 31 March 2024)
- Application of Botulinum Toxins in Non-spastic and Neurodegenerative Disorders (Deadline: 31 March 2024)
- Botulinum Neurotoxin as Novel Therapy of Spasticity and Disorder Movement (Deadline: 31 March 2024)
- Botulinum Toxins and Children’s Health (Deadline: 30 April 2024)
- Uses of Botulinum Toxin Injection in Medicine (Deadline: 31 May 2024)
- Toxin-Host Interaction of Clostridium Toxins (Deadline: 31 May 2024)
- Botulinum Toxin for Urinary Tract Disease: After a Decade from Approval (Deadline: 31 May 2024)
- Botulinum Toxins Injections for Hypertonic Limbs—Is It So Effective? (Deadline: 31 May 2024)
- Intracellular Transport of Toxins: Insights into Mechanisms of Cytotoxicity and Applications in Cell Biology and Medicine (Deadline: 20 June 2024)
- Biological and Pharmacological Properties of Botulinum Neurotoxins (Deadline: 30 June 2024)
- Advances in Bacillus thuringiensis Toxins (Deadline: 30 June 2024)
- Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? II (Deadline: 30 June 2024)
- The Botulinum Toxin and Spasticity: Exploring New Horizons (Deadline: 30 June 2024)
- Immunogenicity of Botulinum Toxin (Deadline: 25 July 2024)
- ADP-Ribosylation and Beyond (Deadline: 31 July 2024)
- Botulinum Toxin and Migraine: Goals and Perspectives (Volume II) (Deadline: 31 August 2024)
- Foodborne Toxins and Public Health (Deadline: 31 August 2024)
- Botulinum Toxins: New Uses in the Treatment of Diseases (Volume II) (Deadline: 30 September 2024)
- Foodborne Toxins: Immunodetection and Analysis of Pathogenic Bacterial Toxins (Deadline: 31 December 2024)
- Bacillus thuringiensis: A Broader View of Its Biocidal Activity v2.0 (Deadline: 31 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions: